Phenylketonurias

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA approval · 2026-01-07
EMA Authorised: Kuvan (sapropterin dihydrochloride) — BioMarin International Limited
The European Medicines Agency has authorised Kuvan (sapropterin dihydrochloride) for phenylketonurias. The marketing authorization holder is…